Dr Stefanie Reichelt

Human Cell Atlas Science Strategy Manager UK/EU

Stefanie is the HCA UK/EU Science Strategy Manager for the Human Cell Atlas (HCA) initiative. She provides strategic guidance/oversight for the HCA and leads the regional HCA Executive Office team based in the UK. 

In my role as the HCA UK/EU Science Strategy Manager, I am responsible for the strategic scientific delivery of the Human Cell Atlas project (UK/EU) by maintaining a portfolio view of the HCA research delivered by the HCA Principal Investigators (PIs) and project teams. I identify and facilitate strategic scientific opportunities based on the HCA project aims, local strategy of HCA Investigators, funding landscape, and national and global opportunities. Working closely with the HCA Alliance Manager (based at the Broad Institute, US) and HCA PIs, I support UK/EU projects in delivering their research aims within the HCA framework. Within this, I build close relationships and continued partnerships with related strategic initiatives and funders in the UK and EU (Wellcome, Medical Research Council (MRC), INSERM, LifeTime, etc.), and identify potential new partnerships to ensure the success of the project.

Before joining HCA, I established and led the Cancer Research UK Cambridge Institute (CRUK CI)’s Light Microscopy Facility, providing novel imaging techniques & pipelines for cancer research (light microscopy, high-content imaging, non-linear imaging) for over 300 internal and external users including data management, training courses and image analysis developments.

As scientific staff scientist at the Medical Research Council Laboratory of Molecular Biology (MRC-LMB), I contributed to key innovations in laser scanning microscopy working with Brad Amos and on the commercialisation of these instruments with Bio-Rad Microscience. My early career as a molecular cell biologist resulted in publications describing the biological function of the first genetically characterized motor protein (myosin) in plants. My first paper described the first technical implementation of back-scatter electron detection for immuno-gold labelling in SEM, which is now a standard detection method in systems world-wide.

My timeline

 

My publications

Loading publications...

Connect with me on Twitter